A Scalable and High-Growth Cannabis Operator
Cannara Biotech - Initiation of coverage
LOVE (CVE) – Cannara Biotech
Current Price: $1.73 | Market Cap: $163M
All figures in CAD unless otherwise stated.
After following the company for several quarters, meeting management twice in October, and visiting its production facility in Valleyfield this week, we believe Cannara represents a compelling opportunity for investors seeking both growth and margin expansion within the Canadian cannabis sector.
It’s a high-conviction idea for us and a core holding within the Aurelion Index.
The scale and quality of the Valleyfield operations strengthened our conviction in Cannara’s execution capabilities and durable cost advantage.
With growing operational visibility, industry-leading margins, and ongoing capacity expansion, we believe it’s positioned for sustained earnings growth and a potential valuation re-rating.